id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
bam-10671	Saffarieh, Elham; Nassiri, Setare; Mirmohammadkhani, Majid	Predicting value of HE4 and CA125 markers for optimal cytoreductive surgery in ovarian cancer patients	2022	7	.pdf	application/pdf	4395	253	59	HE4 and CA125 markers in ovarian cancer patients Eur J Transl Myol 32 (3): 10671, 2022 doi: 10.4081/ejtm.2022.10671 - 4 - considered the standard of care in ovarian cancer. The difficulties of management of advanced ovarian cancer led to a new definition in cytoreductive surgery in which, the size of maximum HE4 and CA125 markers in ovarian cancer patients Eur J Transl Myol 32 (3): 10671, 2022 doi: 10.4081/ejtm.2022.10671 - 2 - residual tissue < 2 cm changed into no macroscopic residual tumor.10 Advanced ovarian cancer has raised a multitude of questions about contemplating the best procedure and taking some drastic measures.	cache/bam-10671.pdf	txt/bam-10671.txt
